Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Garinot

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|June 22, 2023
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery systemMarie-Clotilde Bernard, Emilie Bazin, Nadine Petiot, et al.
Frontiers in Immunology|July 24, 2019
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFloriane Auderset, Marie Ballester, Beatris Mastelic-Gavillet, et al.
NPJ Vaccines|December 20, 2024
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidateErnesto Luna, Sophie Ruiz, Marie Garinot, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|June 22, 2023
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery systemMarie-Clotilde Bernard, Emilie Bazin, Nadine Petiot, et al.
Frontiers in Immunology|July 24, 2019
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFloriane Auderset, Marie Ballester, Beatris Mastelic-Gavillet, et al.
NPJ Vaccines|December 20, 2024
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidateErnesto Luna, Sophie Ruiz, Marie Garinot, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Pageof 2